Brent L Saunders Bridge Bio Pharma, Inc. (BBIO) insider trading activity
Brent L Saunders is Director of BridgeBio Pharma, Inc.. Currently has a direct ownership of 17,600 shares of BBIO, which is worth approximately $405,504. The most recent transaction as insider was on Dec 29, 2021, when has been sold 17,600 shares (Common Stock) at a price of $14.48 per share, resulting in proceeds of $254,848. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
17.6K
0%
3M change
0%
12M change
Total Value Held
$405,504
BRENT L SAUNDERS Transaction History
Also insider at
BLS
Brent L Saunders
Director
San Jose, CA